Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Tertomotide by GemVax & KAEL for Breast Cancer: Likelihood of Approval
Tertomotide is under clinical development by GemVax & KAEL and currently in Phase I for Breast Cancer. According to GlobalData,...
Data Insights
Tertomotide by GemVax & KAEL for Alzheimer's Disease: Likelihood of Approval
Tertomotide is under clinical development by GemVax & KAEL and currently in Phase II for Alzheimer's Disease. According to GlobalData,...